What is IQV's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 42.78B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for IQV?

P/E (TTM) is 31.11 and 52-week range is $154.50 to $277.40 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s IQV figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for IQV?

The company profile lists revenue (TTM) near $16.71B, net income (TTM) near $1.35B, EPS (TTM) near $8.07 when available from the market-data feed. Figures are informational and may lag live markets.

Where is IQVIA Holdings Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Durham, North Carolina, US, 164.6M shares outstanding, ISIN US46266C1053 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

IQVIA Holdings Inc

$IQV

Health Care · Life Sciences Tools & Services

IR Run Scenarios

$259.88

+0.39%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

Employees

93,000

Website

ir.iqvia.com/

IPO

2013-05-09

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)